LTRN
Lantern Pharma
$2.79
+$0.04 (+1.45%)Jul 27, 2026
Key metrics
The numbers that frame LTRN today
- Market cap
- $31.54M
- P/E (TTM)
- -2.0
- EV / FCF
- -1.8
- ROIC
- -732.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.11
- 52wk High
- $5.74
Growth
Revenue and earnings trend for LTRN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LTRN
Is Lantern Pharma a good buy?
Hold. Lantern Pharma has strong momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case. We think Lantern Pharma is selling at a very high price.
What is the market capitalization of LTRN?
Lantern Pharma's market capitalization is $31.54M.
What is the P/E ratio for LTRN stock?
Lantern Pharma's current P/E ratio is -2.
What is the 52-week high for LTRN stock?
The 52-week high for Lantern Pharma is $5.74. The current close of $2.79 is 51.4% below that high.
What is the 52-week low for LTRN stock?
The 52-week low for Lantern Pharma is $1.11. The current close of $2.79 is 151.4% above that low.
Does LTRN stock pay dividends?
Lantern Pharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LTRN?
Lantern Pharma's Debt / Equity ratio is 0.02.